NCT02354742

Brief Summary

Echocardiography (cardiac ultrasound) is being used more often in the critical care setting for management of severe infection (septic shock). Early studies show echocardiography to be useful in these patients, but at this time, there are no good clinical trials to justify its use. Our study goals/objectives are as follows:

  1. 1.To conduct an unblinded, two-group randomized controlled clinical trial to compare an echocardiography-guided resuscitation protocol with an Early Goal Directed Therapy (EGDT) protocol in patients with severe sepsis or septic shock.
  2. 2.Demonstrate that a sepsis treatment protocol using transthoracic echocardiography and other non-invasive assessments of cardiac output will result in more rapid resolution of septic shock compared to invasive EGDT.
  3. 3.Demonstrate patients receiving the non-invasive echocardiography protocol will receive less administration of intravenous fluid.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 3, 2014

Completed
28 days until next milestone

Study Start

First participant enrolled

December 1, 2014

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 3, 2015

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2017

Completed
Last Updated

July 16, 2018

Status Verified

July 1, 2018

Enrollment Period

2.4 years

First QC Date

November 3, 2014

Last Update Submit

July 13, 2018

Conditions

Keywords

EchocardiographyEGDTSepsis

Outcome Measures

Primary Outcomes (1)

  • Comparison of Serial organ failure assessment (SOFA) scores in both treatment arms

    up to 72 hours

Secondary Outcomes (5)

  • Inpatient mortality in both treatment arms

    Up to ~7 days (Occurring during hospital stay).

  • Time to lactate clearance in both treatment arms

    Up to ~7 days (Occurring during ICU hospital stay).

  • Number of ICU-Free days

    28 days

  • Daily and cumulative fluid balance in both treatment arms

    Up to ~7 days (Occurring during ICU hospital stay).

  • Number of ventilator-free days

    Up to ~7 days (Occurring during ICU hospital stay).

Study Arms (2)

Early Goal Directed Therapy (EGDT)

ACTIVE COMPARATOR

EGDT is currently standard of care in management of septic shock, so assignment to this treatment arm will confer no additional risk above that of standard of care. EGDT utilizes placement of a central venous catheter, an arterial catheter, and administration of intravenous fluid and vasoactive medications. EGDT uses central venous catheter to assess central venous pressure and ScVO2.

Other: EGDT fluid resuscitation

Echo Guided Fluid Resuscitation

EXPERIMENTAL

The echo arm also utilizes placement of a central venous catheter, an arterial catheter, and administration of intravenous fluid and vasoactive medications, all of which are interventions found in standard care. The central venous pressure will not be monitored in this arm. Instead, decisions for giving fluids will be directed by the results of Echocardiography. Echocardiography poses no known risk to the patient, and it is non-invasive. The only risk of echocardiography is that of misdiagnosis.

Other: Echo guided fluid resuscitation

Interventions

Patients will have their fluid resuscitation care guided by measurements obtained during an echo.

Echo Guided Fluid Resuscitation

Patients will have their fluid resuscitation care guided by an EGDT protocol, which is currently used as standard of care.

Early Goal Directed Therapy (EGDT)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 18 years of age
  • Suspected infection
  • Two or more systemic inflammatory response syndrome (SIRS) criteria
  • White blood cell count less than 4,000 per mm3, greater than 12,000 per mm3, or differential with greater than 10% immature forms
  • Heart rate greater than 90 beats per minute
  • Respiratory rate greater than 20 breaths per minute or paCO2 less than 32 mmHg
  • Temperature less than 36°C or greater than 38°C
  • Evidence of refractory hypoperfusion attributed to sepsis (one or more of the following):
  • Systolic blood pressure less than 90 mmHg despite an intravenous fluid challenge of at least 30ml/kg (a portion of this may be albumin equivalent)
  • Blood lactate level at least 4 mmol/L.
  • Intention to place an arterial catheter.
  • Intention to place a central venous catheter.

You may not qualify if:

  • Known pregnancy
  • Requirement for immediate surgery
  • Hypotension attributed to alternative cause
  • Treating physician deems the patient is moribund
  • Treating physician deems aggressive care is unsuitable
  • Contraindication to central venous catheterization or arterial catheterization
  • Advanced directives restricting implementation of the protocol
  • Significant pathology of the chest or abdominal wall that would make transthoracic echocardiography impossible (burns, chest trauma, etc.)
  • Children under the age of 18 will not be included in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Intermountain Medical Center

Murray, Utah, 84157, United States

Location

Related Publications (1)

  • Lanspa MJ, Burk RE, Wilson EL, Hirshberg EL, Grissom CK, Brown SM. Echocardiogram-guided resuscitation versus early goal-directed therapy in the treatment of septic shock: a randomized, controlled, feasibility trial. J Intensive Care. 2018 Aug 13;6:50. doi: 10.1186/s40560-018-0319-3. eCollection 2018.

MeSH Terms

Conditions

SepsisShock, Septic

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Officials

  • Michael Lanspa, MD

    Intermountain Health Care, Inc.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 3, 2014

First Posted

February 3, 2015

Study Start

December 1, 2014

Primary Completion

May 1, 2017

Study Completion

October 1, 2017

Last Updated

July 16, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations